Literature DB >> 21757669

Stem cell research in stroke: how far from the clinic?

Olle Lindvall1, Zaal Kokaia.   

Abstract

Stem cell-based approaches hold much promise as potential novel treatments to restore function after stroke. Studies in animal models have shown that stem cell transplantation can improve function by replacing neurons or by trophic actions, modulation of inflammation, promotion of angiogenesis, remyelination and axonal plasticity, and neuroprotection. Endogenous neural stem cells are also potential therapeutic targets because they produce new neurons after stroke. Clinical trials are ongoing but there is currently no proven stem cell-based therapy for stroke. Preclinical studies and clinical research will be needed to optimize the therapeutic benefit and minimize the risks of stem cells in stroke.

Entities:  

Mesh:

Year:  2011        PMID: 21757669     DOI: 10.1161/STROKEAHA.110.599654

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  54 in total

1.  Intra-arterial transplantation of low-dose stem cells provides functional recovery without adverse effects after stroke.

Authors:  Yuhtaka Fukuda; Nobutaka Horie; Katsuya Satoh; Susumu Yamaguchi; Youichi Morofuji; Takeshi Hiu; Tsuyoshi Izumo; Kentaro Hayashi; Noriyuki Nishida; Izumi Nagata
Journal:  Cell Mol Neurobiol       Date:  2014-11-15       Impact factor: 5.046

2.  Intravenous administration of human umbilical cord blood-derived AC133+ endothelial progenitor cells in rat stroke model reduces infarct volume: magnetic resonance imaging and histological findings.

Authors:  Asm Iskander; Robert A Knight; Zheng Gang Zhang; James R Ewing; Adarsh Shankar; Nadimpalli Ravi S Varma; Hassan Bagher-Ebadian; Meser M Ali; Ali S Arbab; Branislava Janic
Journal:  Stem Cells Transl Med       Date:  2013-08-09       Impact factor: 6.940

3.  The Neural Cell Adhesion Molecule-Derived (NCAM)-Peptide FG Loop (FGL) Mobilizes Endogenous Neural Stem Cells and Promotes Endogenous Regenerative Capacity after Stroke.

Authors:  Rebecca Klein; Nicolas Mahlberg; Maurice Ohren; Anne Ladwig; Bernd Neumaier; Rudolf Graf; Mathias Hoehn; Morten Albrechtsen; Stephen Rees; Gereon Rudolf Fink; Maria Adele Rueger; Michael Schroeter
Journal:  J Neuroimmune Pharmacol       Date:  2016-06-28       Impact factor: 4.147

Review 4.  Neurotrophin Signaling and Stem Cells-Implications for Neurodegenerative Diseases and Stem Cell Therapy.

Authors:  Subrata Pramanik; Yanuar Alan Sulistio; Klaus Heese
Journal:  Mol Neurobiol       Date:  2016-11-05       Impact factor: 5.590

Review 5.  Harnessing stem cells and biomaterials to promote neural repair.

Authors:  K F Bruggeman; N Moriarty; E Dowd; D R Nisbet; C L Parish
Journal:  Br J Pharmacol       Date:  2018-12-21       Impact factor: 8.739

Review 6.  Role of neural precursor cells in promoting repair following stroke.

Authors:  Pooya Dibajnia; Cindi M Morshead
Journal:  Acta Pharmacol Sin       Date:  2012-10-15       Impact factor: 6.150

7.  The synthetic NCAM mimetic peptide FGL mobilizes neural stem cells in vitro and in vivo.

Authors:  Rebecca Klein; Stefan Blaschke; Bernd Neumaier; Heike Endepols; Rudolf Graf; Meike Keuters; Joerg Hucklenbroich; Morten Albrechtsen; Stephen Rees; Gereon Rudolf Fink; Michael Schroeter; Maria Adele Rueger
Journal:  Stem Cell Rev Rep       Date:  2014-08       Impact factor: 5.739

Review 8.  Implantation of human umbilical cord mesenchymal stem cells for ischemic stroke: perspectives and challenges.

Authors:  Yingchen Li; Guoheng Hu; Qilai Cheng
Journal:  Front Med       Date:  2014-12-09       Impact factor: 4.592

9.  In vivo Tracking of Human Neural Stem Cells Following Transplantation into a Rodent Model of Ischemic Stroke.

Authors:  Da-Jeong Chang; Hyeyoung Moon; Yong Hyun Lee; Nayeon Lee; Hong J Lee; Iksoo Jeon; Hyunseung Lee; Tae-Sun Hwang; Seung-Hun Oh; Dong Ah Shin; Seung U Kim; Kwan Soo Hong; Jihwan Song
Journal:  Int J Stem Cells       Date:  2012-05       Impact factor: 2.500

Review 10.  New evidence for therapies in stroke rehabilitation.

Authors:  Bruce H Dobkin; Andrew Dorsch
Journal:  Curr Atheroscler Rep       Date:  2013-06       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.